Paul Goddard's Net Worth
$5.42 Million
Who is Paul Goddard?
Paul Goddard has an estimated net worth of $5.42 Million. This is based on reported shares across multiple companies, which include ARYx Therapeutics, Inc., AP PHARMA INC /DE/, Corium International, Inc., XENOPORT INC, ONYX PHARMACEUTICALS INC, ADOLOR CORP, and MOLECULAR DEVICES CORP.
SEC CIK
Paul Goddard's CIK is 0001227124
Past Insider Trading and Trends
2011 was Paul Goddard's most active year for acquiring shares with 11 total transactions. Paul Goddard's most active month to acquire stocks was the month of April. 2013 was Paul Goddard's most active year for disposing of shares, totalling 32 transactions. Paul Goddard's most active month to dispose stocks was the month of July. 2013 saw Paul Goddard paying a total of $548,490.00 for 32,000 shares, this is the most they've acquired in one year. In 2013 Paul Goddard cashed out on 112,516 shares for a total of $4,203,014.85, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARYx Therapeutics, Inc. No price found
Chairman & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| +5.58% | 3.02K |
—
|
—
| 57.19K |
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AP PHARMA INC /DE/ (HRTX) Snapshot price: $1.81
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 4
| +80.72% | 95.89K |
—
|
—
| 214.68K |
Oct 24 - May 20
| |||
Form 4
| +13.41% | 14.04K |
—
|
—
| 118.79K |
Feb 17
| |||
Form 4
| +201.44% | 70K |
—
|
—
| 104.75K |
May 27
| |||
Form 4
| +34.95% | 9K |
$0.01 | $90.00 | 34.75K |
May 28
| |||
Form 4
|
∞
| 18.25K |
$0.01 | $182.50 | 18.25K |
Jan 15
| |||
Form 4
| +28.57% | 10K |
$1.50 | $15,000.00 | 45K |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
| 65K |
Apr 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
| No matching records found | |||||||||
Corium International, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XENOPORT INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.39% | 1.67K |
—
|
—
| 50.83K |
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ONYX PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -14.89K |
$125.00 | -$1,861,250.00 |
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
$77.66 | -$654,637.85 | 14.89K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$61.71 | -$66,590.00 | 14.89K |
Scheduled
|
May 8
| ||
Form 4
|
—
|
0
|
$54.35 | -$386,677.00 | 14.89K |
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$61.71 | -$133,180.00 | 14.89K |
Scheduled
|
Apr 10
| ||
Form 4
| +16.42% | 2.1K |
—
|
—
| 14.89K |
Mar 28
| |||
Form 4
|
—
|
0
|
$56.71 | -$56,590.00 | 12.79K |
Scheduled
|
Mar 8
| ||
Form 4
|
—
|
0
|
$43.43 | -$247,400.00 | 12.79K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$58.38 | -$248,200.00 | 12.79K |
Scheduled
|
Jan 9
| ||
Form 4
|
—
|
0
|
$38.09 | -$333,100.00 | 12.79K |
Aug 30
| |||
Form 4
| +13.29% | 1.5K |
—
|
—
| 12.79K |
Jul 25
| |||
Form 4
| +36.19% | 3K |
—
|
—
| 11.29K |
Mar 30
| |||
Form 4
| +56.71% | 3K |
—
|
—
| 8.29K |
Mar 31
| |||
Form 4
| +23.31% | 1K |
—
|
—
| 5.29K |
May 26
| |||
Form 4
| +87.34% | 2K |
—
|
—
| 4.29K |
Mar 31
| |||
Form 4
|
∞
| 2.29K |
—
|
—
| 2.29K |
Mar 31
| |||
Form 4
|
—
|
0
|
$30.85 | -$181,035.55 |
0
|
Aug 18
| |||
Form 4
|
—
|
0
|
$25.37 | -$145,611.50 |
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
$19.31 | -$307,688.50 |
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
$30.23 | -$234,805.00 |
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
$18.98 | -$80,976.36 |
0
|
Nov 26
| |||
Form 4
|
—
|
0
|
$17.43 | -$98,231.50 |
0
|
Nov 14
| |||
| No matching records found | |||||||||